News+

Radical changes will be needed for worldwide universal health care

Worldwide universal health care seems all but inevitable, says a new Chan School analysis, but doctors, administrators, and politicians will need to tread lightly lest they undermine UHC’s potential gains. Credit: pixabay.com

4 min read

Technological innovation, expansion of the use of frontline personnel such as community health workers, and rapid increases in health care financing are likely to be instrumental to achieving universal health care (UHC) in countries around the world, according to a new analysis led by Harvard T.H. Chan School of Public Health.

While the idea of UHC is garnering widespread support and is a central imperative for the World Health Organization and the United Nations, the researchers emphasized that countries must strike a balance between expanding health care coverage and ensuring the quality of care that is being delivered. Medical errors, health care-acquired infections, and poor retention of patients in care could undermine gains made under UHC, they said.

“It’s difficult to think of an aspiration that both reflects and contributes to human progress more than UHC. The challenge is delivery, which will require sustained political and financial muscle in addition to innovative technologies and institutions. Most importantly, it requires that we avoid tunnel vision conceptions of UHC that focus predominantly on medical interventions. We must not give short shrift to primary health care or to interventions that promote disease prevention and early detection, social and economic equity, and international cooperation,” said David Bloom, co-author and Clarence James Gamble Professor of Economics and Demography at Harvard Chan School.

The analysis was published online on Aug. 23, 2018 in Science.

Forty years ago this September, world health leaders issued the Alma-Ata Declaration, which raised global awareness of “health for all” as a universal human right and emphasized the importance of primary health care. The benefits of UHC are plentiful and extend beyond improving health. UHC may lead to economic gains by increasing productivity, the researchers said, and it can improve social and political stability while reducing health disparities and economic and social inequalities. Additionally, countries in which the bulk of healthcare spending is prepaid by government financing have lower rates of the type of catastrophic health expenditures that can bankrupt families when compared with countries that rely on private insurance schemes.

Since the Alma-Ata Declaration, high-income countries have made significant strides toward UHC. Today, according to the researchers, the U.S. is the only high-income country in the world that does not explicitly provide UHC to its citizens. Progress toward UHC in low- and middle-income countries has not been as swift, especially among countries located in sub-Saharan Africa and South Asia, according to the analysis.  Among the biggest challenges is the need to rapidly increase health care financing in low- and middle-income countries, where populations are simultaneously growing in size and getting older.

Achieving UHC in low-resource settings will likely require a radical transformation in the way health services are delivered. Shifting certain medical tasks from highly trained personnel to appropriately well-trained personnel – such as community health workers – could prove to be an important step. The researchers also said that adopting innovative technologies such as electronic medical records, telemedicine, and artificial intelligence for interpretation of x-rays and electrocardiograms, may also help.

Research by D.E.B. reported in this manuscript was supported by the National Institute on Aging of the National Institutes of Health under award number P30AG024409. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. D.E.B.’s research on this manuscript was also made possible by a grant from the Carnegie Corporation of New York. R.S. acknowledges support from a grant from the Bill and Melinda Gates Foundation via the Arcady Group (OPP1154665) and a Doris Duke Clinical Scientist Development Award.